Dr Ceri Mathews
Senior Business Development Manager
Ceri holds a BSc in Physiological Sciences and a PhD in ion channel physiology from the University of Newcastle-upon-Tyne. He also holds an MBA awarded by Durham Business School. Ceri is an experienced technology transfer professional with over 20 years’ experience of identifying, protecting and commercialising opportunities in the life sciences and medtech sectors.
Ceri joined the ICR in 2022 having previously worked for King’s College London, where he led on commercialising a wide range of technologies arising mainly from their School of Biomedical Engineering and Imaging Sciences. Prior to joining King’s, Ceri worked with a number of government research agencies, including Dstl and UK Health Security Agency, to commercially exploit research outputs via licensing technologies to existing companies or newly-formed spin-outs.
Ceri’s team works closely with the ICR’s Divisions of Clinical Studies, Genetics and Epidemiology, Molecular Pathology and Radiotherapy and Imaging, which have extensive interactions with industry, to support the development and translation of new cancer diagnostics, prognostics, treatments and technologies.
Contact: [email protected] or T: 020 3437 6884 or M: 07840 841 369